Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sinovac Biotech Ltd (NASDAQ:SVA)

5.20
Delayed Data
As of Sep 03
 -0.18 / -3.35%
Today’s Change
4.51
Today|||52-Week Range
6.00
-0.57%
Year-to-Date
No recent news for Sinovac Biotech Ltd.

Today’s Trading

Previous close5.38
Today’s open5.45
Day’s range5.19 - 5.45
Volume29,323
Average volume (3 months)112,459
Market cap$300.3M
Dividend yield--
Data as of 09/03/2015

Growth & Valuation

Earnings growth (last year)-115.38%
Earnings growth (this year)-150.00%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)-12.99%
P/E ratio206.0
Price/Sales4.62
Price/Book2.37

Competitors

 Today’s
change
Today’s
% change
TKAITokai Pharmaceutical...+0.45+3.39%
NAVBNavidea Biopharmaceu...+0.03+1.52%
POZNPOZEN Inc-0.46-5.08%
FOMXFoamix Pharmaceutica...-0.34-3.36%
Data as of 4:00pm ET, 09/03/2015

Financials

Next reporting dateNovember 16, 2015
EPS forecast (this quarter)$0.00
Annual revenue (last year)$63.1M
Annual profit (last year)-$851.0K
Net profit margin-1.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
Secretary
Wei Dong Yin
Chief Financial Officer
Nan Wang
Corporate headquarters
Beijing, Beijing

Forecasts

Partner Offers